Abiopharma

Diversified Energy Response to Media Speculation

AKVA group ASA: Q2 2026 financial reporting

Dormant shares - change in the number of shares

Ceased to be an interested party - Tania Friedman

General Announcement: Net Asset Value ("NAV") as of 13 August 2026

General Announcement: General Announcement

BW LPG Limited – Q2 2026 Financial Report Release and Earnings Presentation on 28 August 2026

Pfizer Inc. - Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Management and officers – staffing as of 14.8.26

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

Mandatory Cash Dividend/ Distribution:

General Announcement: Foundation Healthcare Holdings 1H2026 Earnings Call Script

Western Union and Intermex Provide Update on Pending Acquisition